Clinical Trials Directory

Trials / Unknown

UnknownNCT05925738

Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer

Positron Emission Tomography/ Computed Tomography (PET/CT) Based Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting aggressive histological pattern in resected non-small cell lung cancer based on a multicenter prospective cohort.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPET/CT-based Deep Learning SignatureDeep Learning Signature Based on PET-CT for Predicting the Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer

Timeline

Start date
2023-05-01
Primary completion
2023-10-31
Completion
2023-10-31
First posted
2023-06-29
Last updated
2023-06-29

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05925738. Inclusion in this directory is not an endorsement.